14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages

[1]  P. Cras,et al.  14-3-3 γ-isoform detection distinguishes sporadic Creutzfeldt–Jakob disease from other dementias , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Y. Itoyama,et al.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease , 2004, Neurology.

[3]  S. Marie,et al.  14-3-3 protein in the CSF of patients with rapidly progressive dementia , 2003, Neurology.

[4]  R. Sánchez-Valle,et al.  14-3-3 protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt–Jakob disease , 2002, Neuroscience Letters.

[5]  H. Baxter,et al.  Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain , 2002, Neuroscience.

[6]  S. Oka,et al.  Increased concentrations of 14-3-3ε, γ and ζ isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction , 2001 .

[7]  D. McKeel,et al.  Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[8]  F. Baas,et al.  14-3-3 testing in diagnosing Creutzfeldt–Jakob disease , 2000, Neurology.

[9]  J. Kornhuber,et al.  Isoform Pattern of 14‐3‐3 Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt‐Jakob Disease , 1999, Journal of neurochemistry.

[10]  H. Wakabayashi,et al.  Increased Levels of ɛ and γ Isoforms of 14-3-3 Proteins in Cerebrospinal Fluid in Patients with Creutzfeldt-Jakob Disease , 1999, Clinical Diagnostic Laboratory Immunology.

[11]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[12]  J. Laplanche,et al.  14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[13]  O. Gefeller,et al.  Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[14]  T. L. Collins,et al.  Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function , 1996, Molecular and cellular biology.

[15]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[16]  H. Kretzschmar,et al.  Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease , 1995, The Lancet.

[17]  J Vandekerckhove,et al.  Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. , 1993, Journal of molecular biology.

[18]  P. Boston,et al.  Human 14‐3‐3 Protein: Radioimmunoassay, Tissue Distribution, and Cerebrospinal Fluid Levels in Patients with Neurological Disorders , 1982, Journal of neurochemistry.

[19]  M. Zeidler,et al.  WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease , 1998 .